Why Option Care Health Stock Zoomed 8% Higher on Tuesday

Source The Motley Fool

Key Points

  • It released its preliminary quarterly and full-year 2025 figures.

  • These indicated a healthy year-over-year rise in revenue and a potential bottom-line bump.

  • 10 stocks we like better than Option Care Health ›

Many investors were opting to grab shares of Option Care Health (NASDAQ: OPCH) during Tuesday's trading session. This followed the niche healthcare company's announcement of preliminary financial results. Encouraged by what they heard, those market players pushed Option Care Health's price up by over 8% that day.

Preliminary optimism

After market close Monday, Option Care Health unveiled those preliminary and unaudited figures. For its fourth quarter of 2025, the company anticipates booking $1.46 billion to $1.47 billion in net sales, compared to $1.35 billion in the same period the previous year.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Two people participating in a telehealth session.

Image source: Getty Images.

As for profitability, Option Care Health estimates it will earn net income not in accordance with generally accepted accounting principles (GAAP) of $73.8 million to $79 million for the quarter. That shakes out to $0.46 to $0.49 per share. The year-ago quarter's non-GAAP (adjusted) net profit was $75.5 million.

The company also announced it is expanding its share buyback program. Its board of directors has authorized management to repurchase up to $1 billion of its equity, exactly double the $500 that was authorized last year. At the end of 2025, that original program had $193 million remaining in purchase capacity.

Positive prognosis

In contrast to an "official" earnings release, a preliminary one doesn't necessarily offer commentary on the covered quarter. Option Care Health didn't discuss either its fourth quarter or full-year performance at all.

Regardless, the company's doubling of its stock buyback initiative shows it's heading into the still-new year with plenty of confidence in its business. If I were a shareholder, I'd also be encouraged by that more than 8% year-over-year increase in revenue.

Should you buy stock in Option Care Health right now?

Before you buy stock in Option Care Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Option Care Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $482,209!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,133,548!*

Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 13, 2026.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold selling pressure persists as traders lock in profits ahead of US NFP reportGold (XAU/USD) remains under some selling pressure for the second straight day and slides back closer to the overnight swing low during the Asian session on Thursday. The downtick lacks any fundamental catalyst and is likely to remain limited amid a supportive fundamental backdrop.
Author  FXStreet
Jan 08, Thu
Gold (XAU/USD) remains under some selling pressure for the second straight day and slides back closer to the overnight swing low during the Asian session on Thursday. The downtick lacks any fundamental catalyst and is likely to remain limited amid a supportive fundamental backdrop.
placeholder
Top 3 Price Prediction: Bitcoin, Ethereum, Ripple — BTC, ETH and XRP defend key support as rebound scenario stays in playBTC holds above $90,000, ETH hovers near $3,128 at the 50-day EMA, and XRP steadies above $2.07 as traders weigh rebound targets and key downside levels.
Author  Mitrade
Jan 09, Fri
BTC holds above $90,000, ETH hovers near $3,128 at the 50-day EMA, and XRP steadies above $2.07 as traders weigh rebound targets and key downside levels.
placeholder
Solana Future: From high-speed experiment to corporate treasury playbook for the next SOL cycleSolana’s Proof of History architecture is colliding with rising institutional treasury adoption and governance scrutiny, with SOL’s next cycle hinging on validator distribution, stability, and regulated capital access.
Author  Mitrade
Jan 12, Mon
Solana’s Proof of History architecture is colliding with rising institutional treasury adoption and governance scrutiny, with SOL’s next cycle hinging on validator distribution, stability, and regulated capital access.
placeholder
USD/JPY holds positive ground above 158.00 amid Japan's political concernsThe USD/JPY pair trades in positive territory near 158.10 during the early Asian session on Tuesday. The Japanese Yen (JPY) softens against the US Dollar (USD) amid political concerns in Japan.
Author  FXStreet
Yesterday 01: 35
The USD/JPY pair trades in positive territory near 158.10 during the early Asian session on Tuesday. The Japanese Yen (JPY) softens against the US Dollar (USD) amid political concerns in Japan.
placeholder
Meme Coins Price Prediction: DOGE, SHIB and PEPE struggle to stabilize as sellers keep controlDOGE steadies near $0.1350 above $0.1332 support, SHIB holds the 50-day EMA at $0.00000834, and PEPE stays above $0.00000500 as momentum signals warn of further downside.
Author  Mitrade
20 hours ago
DOGE steadies near $0.1350 above $0.1332 support, SHIB holds the 50-day EMA at $0.00000834, and PEPE stays above $0.00000500 as momentum signals warn of further downside.
goTop
quote